Avrobio Inc (AVRO)
1.22
-0.01
(-0.81%)
USD |
NASDAQ |
May 03, 16:00
1.23
+0.01
(+0.82%)
After-Hours: 20:00
Avrobio Max Drawdown (5Y): 98.90% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 98.90% |
| March 31, 2024 | 98.90% |
| February 29, 2024 | 98.90% |
| January 31, 2024 | 98.90% |
| December 31, 2023 | 98.90% |
| November 30, 2023 | 98.90% |
| October 31, 2023 | 98.90% |
| September 30, 2023 | 98.90% |
| August 31, 2023 | 98.90% |
| July 31, 2023 | 98.90% |
| June 30, 2023 | 98.90% |
| May 31, 2023 | 98.90% |
| April 30, 2023 | 98.89% |
| March 31, 2023 | 98.89% |
| February 28, 2023 | 98.89% |
| January 31, 2023 | 98.89% |
| December 31, 2022 | 98.89% |
| November 30, 2022 | 98.89% |
| October 31, 2022 | 98.89% |
| September 30, 2022 | 98.78% |
| August 31, 2022 | 98.58% |
| July 31, 2022 | 98.58% |
| June 30, 2022 | 98.58% |
| May 31, 2022 | 98.58% |
| April 30, 2022 | 98.25% |
| Date | Value |
|---|---|
| March 31, 2022 | 97.55% |
| February 28, 2022 | 97.38% |
| January 31, 2022 | 96.70% |
| December 31, 2021 | 93.45% |
| November 30, 2021 | 92.71% |
| October 31, 2021 | 90.02% |
| September 30, 2021 | 89.51% |
| August 31, 2021 | 89.51% |
| July 31, 2021 | 86.38% |
| June 30, 2021 | 85.12% |
| May 31, 2021 | 85.12% |
| April 30, 2021 | 80.87% |
| March 31, 2021 | 80.87% |
| February 28, 2021 | 80.87% |
| January 31, 2021 | 80.87% |
| December 31, 2020 | 80.87% |
| November 30, 2020 | 80.87% |
| October 31, 2020 | 80.87% |
| September 30, 2020 | 80.87% |
| August 31, 2020 | 80.87% |
| July 31, 2020 | 80.87% |
| June 30, 2020 | 80.87% |
| May 31, 2020 | 80.87% |
| April 30, 2020 | 80.87% |
| March 31, 2020 | 80.87% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
76.36%
Minimum
May 2019
98.90%
Maximum
May 2023
89.49%
Average
91.37%
Median
Max Drawdown (5Y) Benchmarks
| Axonics Inc | 61.24% |
| Catalent Inc | 77.62% |
| AIM ImmunoTech Inc | 99.76% |
| Protalix BioTherapeutics Inc | 94.35% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -58.30 |
| Beta (5Y) | 1.241 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 83.21% |
| Historical Sharpe Ratio (5Y) | -0.5345 |
| Historical Sortino (5Y) | -1.055 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.71% |